General
Preferred name
Tagatose
Synonyms
(3S,4S,5R)-1,3,4,5,6-Pentahydroxyhexan-2-one ()
Tagatose, D- (8CI) ()
D-Tagatose ()
D-(-)-Tagatose ()
D-tagatose ()
P&D ID
PD008674
CAS
17598-81-1
87-81-0
Tags
drug candidate
natural product
available
Drug Status
investigational
Max Phase
Phase 3
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
METABOLISM
Tagatose does not influence the level of blood glucose nor insulin levels.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
MedChem Express Bioactive Compound Library
NPC Screening Collection
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
30
Molecular Weight
180.06
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
5
Rotatable Bonds
5
Ring Count
0
Aromatic Ring Count
0
cLogP
-3.38
TPSA
118.22
Fraction CSP3
0.83
Chiral centers
3.0
Largest ring
0.0
QED
0.3
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
PYGL
Endogenous Metabolite
MOA
Phosphorylase inhibitor
Pathway
Metabolic Enzyme/Protease
Source data
